Medrx Co. Ltd.

04/24/2024 | Press release | Distributed by Public on 04/23/2024 17:51

MEDRx Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia